- Home
- CLB vs CBLL Comparison
CLB vs CBLL Comparison
Compare CLB & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLB
- CBLL
- Stock Information
- Founded
- CLB 1936
- CBLL 2014
- Country
- CLB United States
- CBLL United States
- Employees
- CLB N/A
- CBLL N/A
- Industry
- CLB
- CBLL
- Sector
- CLB
- CBLL
- Exchange
- CLB Nasdaq
- CBLL Nasdaq
- Market Cap
- CLB 482.5M
- CBLL 433.7M
- IPO Year
- CLB 1995
- CBLL 2024
- Fundamental
- Price
- CLB $12.04
- CBLL $11.86
- Analyst Decision
- CLB Hold
- CBLL Strong Buy
- Analyst Count
- CLB 2
- CBLL 6
- Target Price
- CLB $12.50
- CBLL $33.00
- AVG Volume (30 Days)
- CLB 496.6K
- CBLL 258.1K
- Earning Date
- CLB 10-22-2025
- CBLL 11-11-2025
- Dividend Yield
- CLB 0.34%
- CBLL N/A
- EPS Growth
- CLB 23.99
- CBLL N/A
- EPS
- CLB 0.62
- CBLL N/A
- Revenue
- CLB $517,378,000.00
- CBLL $77,419,000.00
- Revenue This Year
- CLB N/A
- CBLL $35.46
- Revenue Next Year
- CLB $2.23
- CBLL $28.18
- P/E Ratio
- CLB $19.22
- CBLL N/A
- Revenue Growth
- CLB 0.70
- CBLL 42.16
- 52 Week Low
- CLB $9.72
- CBLL $10.01
- 52 Week High
- CLB $21.83
- CBLL $32.75
- Technical
- Relative Strength Index (RSI)
- CLB 49.28
- CBLL 47.16
- Support Level
- CLB $11.98
- CBLL $11.20
- Resistance Level
- CLB $12.79
- CBLL $12.99
- Average True Range (ATR)
- CLB 0.50
- CBLL 0.55
- MACD
- CLB -0.08
- CBLL 0.14
- Stochastic Oscillator
- CLB 18.84
- CBLL 41.94
About CLB Core Laboratories Inc.
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.